Mingjuan Liu is a seasoned marketing professional with extensive experience in the biotechnology sector. Currently serving as the Director of Marketing for North America at uBriGene Biosciences International Co. since March 2024, Liu previously held roles such as Director of BD TS & Marketing at Forecyte Bio Limited and Marketing Lead of Gene Therapy at Charles River Laboratories. Liu's expertise includes strategic marketing for viral vectors, plasmid products, and gene and cell therapy within CGMP manufacturing. Earlier positions include Associate Director at Vigene Biosciences and Marketing Manager at OriGene Technologies, where Liu successfully launched and managed various molecular biology products. Liu began a career at HMS as a researcher focusing on interferon regular factor 3 and holds a Ph.D. in Molecular and Cell Biology from the University of Maryland Baltimore.